Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the risks of the newest experimental drug for Alzheimer’s disease. Alzheimer’s…